Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules

Bo He, Arnaud Jabouille, Veronica Steri, Anna Johansson-Percival, Iacovos P. Michael, Venkata Ramana Kotamraju, Reimar Junckerstorff, Anna K. Nowak, Juliana Hamzah, Gabriel Lee, Gabriele Bergers, Ruth Ganss

Research output: Contribution to journalArticle

8 Citations (Scopus)
229 Downloads (Pure)

Abstract

High-grade brain cancer such as glioblastoma (GBM) remains an incurable disease. A common feature of GBM is the angiogenic vasculature, which can be targeted with selected peptides for payload delivery. We assessed the ability of micelle-tagged, vascular homing peptides RGR, CGKRK and NGR to specifically bind to blood vessels in syngeneic orthotopic GBM models. By using the peptide CGKRK to deliver the tumour necrosis factor (TNF) superfamily member LIGHT (also known as TNF superfamily member 14; TNFSF14) to angiogenic tumour vessels, we have generated a reagent that normalizes the brain cancer vasculature by inducing pericyte contractility and re-establishing endothelial barrier integrity. LIGHT-mediated vascular remodelling also activates endothelia and induces intratumoural high endothelial venules (HEVs), which are specialized blood vessels for lymphocyte infiltration. Combining CGKRK–LIGHT with anti-vascular endothelial growth factor and checkpoint blockade amplified HEV frequency and T-cell accumulation in GBM, which is often sparsely infiltrated by immune effector cells, and reduced tumour burden. Furthermore, CGKRK and RGR peptides strongly bound to blood vessels in freshly resected human GBM, demonstrating shared peptide-binding activities in mouse and human primary brain tumour vessels. Thus, peptide-mediated LIGHT targeting is a highly translatable approach in primary brain cancer to reduce vascular leakiness and enhance immunotherapy.

Original languageEnglish
Pages (from-to)209-221
Number of pages13
JournalJournal of Pathology
Volume245
Issue number2
DOIs
Publication statusPublished - 1 Jun 2018

Fingerprint

Venules
Brain Neoplasms
Blood Vessels
Glioblastoma
Light
Peptides
Tumor Necrosis Factor-alpha
Pericytes
Micelles
Tumor Burden
Immunotherapy
Vascular Endothelial Growth Factor A
Endothelium
Lymphocytes
T-Lymphocytes
Neoplasms

Cite this

He, Bo ; Jabouille, Arnaud ; Steri, Veronica ; Johansson-Percival, Anna ; Michael, Iacovos P. ; Kotamraju, Venkata Ramana ; Junckerstorff, Reimar ; Nowak, Anna K. ; Hamzah, Juliana ; Lee, Gabriel ; Bergers, Gabriele ; Ganss, Ruth. / Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. In: Journal of Pathology. 2018 ; Vol. 245, No. 2. pp. 209-221.
@article{b2a1113994e8483886a75dab3b7b83cd,
title = "Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules",
abstract = "High-grade brain cancer such as glioblastoma (GBM) remains an incurable disease. A common feature of GBM is the angiogenic vasculature, which can be targeted with selected peptides for payload delivery. We assessed the ability of micelle-tagged, vascular homing peptides RGR, CGKRK and NGR to specifically bind to blood vessels in syngeneic orthotopic GBM models. By using the peptide CGKRK to deliver the tumour necrosis factor (TNF) superfamily member LIGHT (also known as TNF superfamily member 14; TNFSF14) to angiogenic tumour vessels, we have generated a reagent that normalizes the brain cancer vasculature by inducing pericyte contractility and re-establishing endothelial barrier integrity. LIGHT-mediated vascular remodelling also activates endothelia and induces intratumoural high endothelial venules (HEVs), which are specialized blood vessels for lymphocyte infiltration. Combining CGKRK–LIGHT with anti-vascular endothelial growth factor and checkpoint blockade amplified HEV frequency and T-cell accumulation in GBM, which is often sparsely infiltrated by immune effector cells, and reduced tumour burden. Furthermore, CGKRK and RGR peptides strongly bound to blood vessels in freshly resected human GBM, demonstrating shared peptide-binding activities in mouse and human primary brain tumour vessels. Thus, peptide-mediated LIGHT targeting is a highly translatable approach in primary brain cancer to reduce vascular leakiness and enhance immunotherapy.",
keywords = "angiogenesis, glioblastoma, immunotherapy, LIGHT, TNFSF14, vascular targeting",
author = "Bo He and Arnaud Jabouille and Veronica Steri and Anna Johansson-Percival and Michael, {Iacovos P.} and Kotamraju, {Venkata Ramana} and Reimar Junckerstorff and Nowak, {Anna K.} and Juliana Hamzah and Gabriel Lee and Gabriele Bergers and Ruth Ganss",
year = "2018",
month = "6",
day = "1",
doi = "10.1002/path.5080",
language = "English",
volume = "245",
pages = "209--221",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley & Sons",
number = "2",

}

Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. / He, Bo; Jabouille, Arnaud; Steri, Veronica; Johansson-Percival, Anna; Michael, Iacovos P.; Kotamraju, Venkata Ramana; Junckerstorff, Reimar; Nowak, Anna K.; Hamzah, Juliana; Lee, Gabriel; Bergers, Gabriele; Ganss, Ruth.

In: Journal of Pathology, Vol. 245, No. 2, 01.06.2018, p. 209-221.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules

AU - He, Bo

AU - Jabouille, Arnaud

AU - Steri, Veronica

AU - Johansson-Percival, Anna

AU - Michael, Iacovos P.

AU - Kotamraju, Venkata Ramana

AU - Junckerstorff, Reimar

AU - Nowak, Anna K.

AU - Hamzah, Juliana

AU - Lee, Gabriel

AU - Bergers, Gabriele

AU - Ganss, Ruth

PY - 2018/6/1

Y1 - 2018/6/1

N2 - High-grade brain cancer such as glioblastoma (GBM) remains an incurable disease. A common feature of GBM is the angiogenic vasculature, which can be targeted with selected peptides for payload delivery. We assessed the ability of micelle-tagged, vascular homing peptides RGR, CGKRK and NGR to specifically bind to blood vessels in syngeneic orthotopic GBM models. By using the peptide CGKRK to deliver the tumour necrosis factor (TNF) superfamily member LIGHT (also known as TNF superfamily member 14; TNFSF14) to angiogenic tumour vessels, we have generated a reagent that normalizes the brain cancer vasculature by inducing pericyte contractility and re-establishing endothelial barrier integrity. LIGHT-mediated vascular remodelling also activates endothelia and induces intratumoural high endothelial venules (HEVs), which are specialized blood vessels for lymphocyte infiltration. Combining CGKRK–LIGHT with anti-vascular endothelial growth factor and checkpoint blockade amplified HEV frequency and T-cell accumulation in GBM, which is often sparsely infiltrated by immune effector cells, and reduced tumour burden. Furthermore, CGKRK and RGR peptides strongly bound to blood vessels in freshly resected human GBM, demonstrating shared peptide-binding activities in mouse and human primary brain tumour vessels. Thus, peptide-mediated LIGHT targeting is a highly translatable approach in primary brain cancer to reduce vascular leakiness and enhance immunotherapy.

AB - High-grade brain cancer such as glioblastoma (GBM) remains an incurable disease. A common feature of GBM is the angiogenic vasculature, which can be targeted with selected peptides for payload delivery. We assessed the ability of micelle-tagged, vascular homing peptides RGR, CGKRK and NGR to specifically bind to blood vessels in syngeneic orthotopic GBM models. By using the peptide CGKRK to deliver the tumour necrosis factor (TNF) superfamily member LIGHT (also known as TNF superfamily member 14; TNFSF14) to angiogenic tumour vessels, we have generated a reagent that normalizes the brain cancer vasculature by inducing pericyte contractility and re-establishing endothelial barrier integrity. LIGHT-mediated vascular remodelling also activates endothelia and induces intratumoural high endothelial venules (HEVs), which are specialized blood vessels for lymphocyte infiltration. Combining CGKRK–LIGHT with anti-vascular endothelial growth factor and checkpoint blockade amplified HEV frequency and T-cell accumulation in GBM, which is often sparsely infiltrated by immune effector cells, and reduced tumour burden. Furthermore, CGKRK and RGR peptides strongly bound to blood vessels in freshly resected human GBM, demonstrating shared peptide-binding activities in mouse and human primary brain tumour vessels. Thus, peptide-mediated LIGHT targeting is a highly translatable approach in primary brain cancer to reduce vascular leakiness and enhance immunotherapy.

KW - angiogenesis

KW - glioblastoma

KW - immunotherapy

KW - LIGHT

KW - TNFSF14

KW - vascular targeting

UR - http://www.scopus.com/inward/record.url?scp=85046897165&partnerID=8YFLogxK

U2 - 10.1002/path.5080

DO - 10.1002/path.5080

M3 - Article

VL - 245

SP - 209

EP - 221

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -